Radiometer, 2003 Harvard Case Solution & Analysis

In 2003, Radiometer was the world's leading supplier of blood gas analysis equipment and accessories for critical care patients. Based in Denmark, Radiometer sold through a mix of distributors and sales subsidiaries all over the world, and generated revenues of over DKr 1,791 million ($272 million). Blood gas evaluation formed part of the $27.7 billion in-vitro diagnostic market. Although sales were robust, Radiometer stayed focused on its future.

The marketplace for blood gas analysis was growing at a snail’s pace, driven primarily by new technologies that threatened to displace the high volume testing equipment that Radiometer supplied. Radiometer's recent attempts at competing in these brand new technologies had failed. Should it remain focused on blood gas evaluation and redouble its attempts? Or should it turn to other chances for growth? Controlling stockholder and CEO, Johan Schroder, had denied rumors of an expected sale, but an acquisition by a stronger partner could help the company grow into the United States. How should the firm place itself for future accomplishments?

Radiometer, 2003 Case Study Solution

PUBLICATION DATE: September 03, 2014 PRODUCT #: 715409-HCC-ENG

This is just an excerpt. This case is about STRATEGY & EXECUTION

PUBLICATION DATE: September 03, 2014 PRODUCT #: 715409-HCC-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.